Increased care fragmentation among chronically ill, commercially insured patients is associated with higher costs and lower quality of care.
An intervention to increase tobacco treatment rates through care coordination for telephone counseling was effective in raising referral rates and in achieving excellent long-term abstinence.
Using an instrumental variable approach, this study is the first to present causal estimates of the effect of preventive dental visits on overall medical expenditures.
This paper estimates the costs and benefits of over-the-counter (OTC) statins using data on statin use and cardiovascular risk, clinical studies of statin safety and efficacy, and an OTC statin use trial.
This article describes a study of an intervention to engage Medicare Part D beneficiaries in obtaining a comprehensive medication review.
Patients with rheumatoid arthritis self-report a moderate rate of any previous pneumococcal vaccination (54%) and a very low rate of herpes zoster vaccination (8%).
Racial/ethnic minorities are disproportionately at risk for adverse health and financial consequences due to lower health insurance literacy compared with white enrollees.
Physician and patient predictors of hyperlipidemia screening and statin prescription at a large, multihospital regional health center based on electronic health record data.
This article evaluates and compares the effectiveness of shared medical appointments versus regular office visits among Hispanic patients with diabetes.
Patient and treatment heterogeneity were characterized within a sample of nonadherent buprenorphine members; an improved understanding of these factors may optimize patient—treatment matching and intervention efforts.
New case management model achieves success in reducing readmissions and is easily duplicated across the Baptist Health System, Inc.
Member cost negatively affects initial medication adherence and manufacturer coupons can decrease member share by up to 98%.
For cost-effective cures, the drug pricing policy challenge is not simply to lower prices, but also to spread the drug costs among payers.
This analysis examines the associations between adherence to Choosing Wisely recommendations embedded into clinical decision support alerts and 4 measures of resource use and quality.